BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 34087152)

  • 1. COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma.
    Prieto PA; Mannava K; Sahasrabudhe DM
    Lancet Oncol; 2021 Jun; 22(6):e281. PubMed ID: 34087152
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
    Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
    Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 4. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
    Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
    Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
    Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S
    JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    Chapin-Bardales J; Gee J; Myers T
    JAMA; 2021 Jun; 325(21):2201-2202. PubMed ID: 33818592
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer and COVID-19 vaccines: a complex global picture.
    Yusuf A; Sarfati D; Booth CM; Pramesh CS; Lombe D; Aggarwal A; Bhoo-Pathy N; Tsunoda A; Vanderpuye V; Kutluk T; Sullivan A; Mukherji D; Mutebi M; van Hemelrijck M; Sullivan R;
    Lancet Oncol; 2021 Jun; 22(6):749-751. PubMed ID: 33930324
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of mRNA-Based Vaccines for SARS CoV-2.
    Barda B; Cerny A
    Chem Res Toxicol; 2021 Aug; 34(8):1823-1825. PubMed ID: 34009959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama T; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Scharf RE; Alberio L
    Hamostaseologie; 2021 Jun; 41(3):179-182. PubMed ID: 34192777
    [No Abstract]   [Full Text] [Related]  

  • 12. Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine.
    Roca B; Rambla M; Roca MM
    J Postgrad Med; 2021; 67(3):180-181. PubMed ID: 34414929
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy.
    Scoccianti S; Delli Paoli C; Grilli Leonulli B; Paoletti L; Alpi P; Caini S; Barca R; Fondelli S; Russo S; Perna M; Pino MS; Martella F; Furlan F; Bassetti A; Fioretto L
    Lancet Oncol; 2021 Sep; 22(9):1212-1214. PubMed ID: 34388385
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women.
    Mortazavi S
    AJR Am J Roentgenol; 2021 Oct; 217(4):857-858. PubMed ID: 33624520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining Safety with SARS-CoV-2 Vaccines.
    Castells MC; Phillips EJ
    N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
    [No Abstract]   [Full Text] [Related]  

  • 16. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
    Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
    Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine.
    Zakaria Z; Sapiai NA; Ghani ARI
    Acta Neurochir (Wien); 2021 Aug; 163(8):2359-2362. PubMed ID: 34101024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
    Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
    Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenopathy Following COVID-19 Vaccination.
    Washington T; Bryan R; Clemow C
    Radiology; 2021 Jun; 299(3):E280-E281. PubMed ID: 33625299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.